Shares of Doximity, Inc. (NYSE:DOCS – Get Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and three have issued a strong buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $44.50.
Several equities analysts have recently issued reports on DOCS shares. Barclays upgraded shares of Doximity to a “strong-buy” rating in a report on Monday, December 8th. The Goldman Sachs Group upgraded Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Needham & Company LLC raised Doximity to a “moderate buy” rating in a report on Friday, February 6th. Canaccord Genuity Group upgraded Doximity from a “hold” rating to a “buy” rating and set a $34.00 price objective on the stock in a report on Monday. Finally, Royal Bank Of Canada upgraded Doximity to a “moderate buy” rating in a research note on Thursday, January 8th.
Read Our Latest Stock Report on DOCS
Doximity Stock Performance
About Doximity
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Read More
- Five stocks we like better than Doximity
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
